MYD88 and renal cell carcinoma: Diao et al. [143] have demonstrated that renal cell carcinoma cells produce TEV containing HSP70 that stimulate the TLR2/Myeloid differentiation primary response protein MyD88 (MyD88)/STAT3 signaling in MDSC, leading to tumor progression.